Product logins

Find logins to all Clarivate products below.


Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers | Medtech 360 | Market Analysis | Europe (Supplemental) | 2016

Surgical procedure volume growth continues to drive the European surgical hemostat, internal tissue sealant, and adhesion barrier market, along with rising awareness of the benefits of these products in surgical outcomes. Additionally, premium-priced product innovations and multi-indication approvals remain key drivers in this space.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the surgical hemostats, internal tissue sealants, and adhesion barriers in Europe, including country-level data for 21 major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Large-Joint Reconstructive Implants – Market Insights – Europe (Supplemental)
The European large-joint reconstructive implant market is poised for long-term growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants, as well as…
Report
Neurovascular Devices – Market Insights – Europe
The European neurovascular device market is poised to experience strong growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2034, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…